1. United Kingdom Stocks

  2. •

    Financial Services

  3. •

    Asset Management - Global
Polar Capital Global Healthcare Trust plc

Polar Capital Global Healthcare Trust plc

PCGH.L
Polar Capital Global Healthcare Trust plcGB flagLondon Stock Exchange
421.00
GBp
+7.00
(+1.69%)
-0.46EPS
-9.15P/E
510.55MMarket Cap
Polar Capital Global Healthcare Trust plc
PCGH.L
(London Stock Exchange)

Recent

price

421.00

P/E

ratio

-9.15

div

yld

- -

ROIC.AI

2011
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
FRC
0.08
0.08
0.25
0.29
0.28
0.14
0.36
0.04
0.43
-0.01
0.35
0.54
0.2
0.17
0.54
Revenue per Share
0.06
0.07
0.24
0.28
0.28
0.13
0.35
0.02
0.41
-0.03
0.33
0.52
0.18
0.14
0.52
Basic EPS, GAAP
- -
-0.95
-0.04
-0.06
-0.11
0.06
0.09
-0.32
0.12
-0.01
0.12
-0.01
-0.03
-0.02
0.4
Free Cash Flow per Basic Share
- -
0.03
0.03
0.03
0.04
0.04
0.04
0.03
0.02
0.02
0.02
0.02
0.02
0.02
0.02
Dividend per Share
0.27
0.28
0.25
0.26
0.26
0.39
0.25
0.26
0.25
0.25
0.26
0.25
0.25
0.25
0.25
Book Value per Share
1.05
1.1
1.23
1.53
1.72
1.74
2.05
2.07
2.46
2.36
2.68
3.18
3.34
3.46
3.95
Tangible Book Value per Share
89
91
98
102
116
121
121
121
121
122
121
121
121
121
121
Basic Weighted Avg Shares
7
7
24
30
33
17
44
4
51
-2
43
65
24
20
66
Sales/Revenue/Turnover
86.23
93.16
98.72
98.74
- -
165.69
98.92
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
6
6
23
29
32
16
43
2
49
-4
40
63
22
17
63
Net Income, GAAP
5.27
7.24
1.98
1.74
1.71
3.92
1.59
26.72
0.89
- -
1.16
0.66
2.42
7.21
1.49
Effective Tax Rate (%)
81.69
86.42
96.77
97.02
97.04
93.59
97.35
45.64
95.71
234.65
94.61
96.77
90.4
84.23
95.86
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
2
- -
- -
- -
- -
41
- -
LT Debt
94
100
121
156
200
210
248
250
296
288
325
386
405
419
479
Total Equity
- -
6.62
21.19
20.71
- -
13.48
18.61
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
25.59
92.85
112.17
112.35
41.96
109.93
6.37
159.33
-12.52
129.76
205.43
71.02
55.73
207.15
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
9.39%
10.83%
14.29%
Free Cash Flow
-432.5%
-702.04%
-2,240.89%
Net Income, GAAP
140.78%
-180.51%
271.69%
Sales/Revenue/Turnover
-148.37%
-497.49%
226.57%
Total Cash Common Dividend
- -
- -
14.25%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
20
2024
- -
- -
- -
- -
66
2025
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.14
2024
- -
- -
- -
- -
0.52
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.02
2024
- -
- -
- -
- -
0.02
2025
- -
- -
- -
- -
- -
Similar Companies
First Trust Europe AlphaDEX Fund (FEP)
Xtrackers MSCI Canada Screened UCITS ETF 1C (D5BH.DE)
Harbor Global Leaders Fund Institutional Class (HGGAX)
Schwab Fundamental Emerging Markets Large Company Index ETF (FNDE)
State Street SPDR Portfolio S&P 500 ETF (SPYM)
iShares MSCI Pacific ex-Japan UCITS ETF (EUNJ.DE)
Business
Polar Capital Global Healthcare Trust plc (PCGH.L) is a closed-end investment trust that seeks capital growth through a diversified global portfolio of listed equities issued by healthcare companies across pharmaceuticals, biotechnology, healthcare equipment and services, and medical devices; the portfolio emphasizes high-conviction investments in growth-oriented firms including top holdings such as Eli Lilly & Co (9.6%), AstraZeneca (5.2%), and Thermo Fisher Scientific (4.4%), with sector allocations of 36.1% to pharmaceuticals, 22.3% to biotechnology, and 13.5% to healthcare equipment, alongside geographic exposure led by the United States (53.2%), Denmark (12.0%), and the United Kingdom (5.2%) across 12 countries in North America, Europe, and Asia. Established in 2010 and headquartered in London, United Kingdom, the Trust is actively managed by Polar Capital LLP, employing fundamental research, active stock-picking, and risk management to target innovative opportunities in the rapidly advancing healthcare industry serving institutional and retail investors globally. In recent developments, the Trust completed a 100% tender offer in November 2025 with overwhelming shareholder support, removed its fixed-life structure in favor of rolling five-yearly tender offers starting with the initial offer on or ahead of March 31, 2031, and implemented a revised charging structure with reduced fees to enhance long-term attractiveness while maintaining its core investment strategy.